CAMBRIDGE, Mass., Oct. 29, 2009 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results for the third quarter ended September 30, 2009 before the U.S. financial markets open on Thursday, November 5, 2009.
